Health ❯ Nutrition

Weight Management

Obesity Medications Weight Loss Lifestyle Changes Obesity Treatments Body Image Dieting Dietary Supplements Weight Loss Drugs Pharmaceuticals

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

A three-year Veterans Affairs analysis ties treatment pauses to higher cardiovascular events.

FDA Approves First Therapy for Acquired Hypothalamic Obesity, Expanding Rhythm’s Imcivree

Serena Williams Posts Swimsuit Photos With 'Perfectly Me' Message as GLP‑1 Controversy Lingers

Novo Nordisk Extends Weight‑Loss Lead as Amgen’s Once‑Monthly MariTide Reaches Phase 3

Luke Combs Opens Up on Popcast About Body-Image Fears, Rejects Weight-Loss Drugs

Viking Therapeutics' Obesity Drug Moves Into Phase 3 as Investors Weigh Upside

Katharina Eisenblut Details Chronic Pain and Tests, Weighs Tummy Tuck After 38‑Kilo Loss

Cochrane Review Finds Intermittent Fasting No Better for Weight Loss Than Standard Dieting

Private GLP-1 Weight-Loss Use in UK Skews to Middle-Class Women, Analysis Shows

McDonald’s Tests Protein-Focused Menu for Customers on GLP-1 Drugs

GLP-1 Boom Rewrites Menus as McDonald's Tests Protein-Forward Options

Paddy Pimblett Weighs 190 Pounds After UFC 324 as Manager Reports Minimal Damage

Resurfaced Cro Cop Interview Condemns MMA Weight Cutting, Revives Questions Over McGregor’s Double-Champ Era

Pitt Study Identifies SerpinB2 as Key to Protective Fat Macrophages, Pointing to a New Diabetes Treatment Path

Roddick Backs Serena Williams’ GLP-1 Use as Training Posts Renew Comeback Buzz

Soha Ali Khan Backs Aishwarya Mohanraj’s Mounjaro Admission, Urges Medical Caution

Obesity Sharply Increases Severe Infection Risk, Lancet Study Finds

Eli Lilly Tightens GLP-1 Grip, Guides Up to $83 Billion for 2026

Eli Lilly Jumps on GLP‑1 Momentum as 2026 Outlook Beats and Targets Rise

Serena Williams’ Super Bowl Ro Ad Promotes GLP-1 Weight Loss, Draws Backlash